Profil
George Bellow is the founder.
He founded SOMAÍ Pharmaceuticals Ltd.
in 2019 and currently holds the title of Chief Operating Officer.
In addition to his founding position, Mr. Bellow also worked as a Non-Executive Director at Uvenco UK Plc.
Postes actifs de George Bellow
| Sociétés | Poste | Début |
|---|---|---|
Somaí Pharmaceuticals Ltd.
 Somaí Pharmaceuticals Ltd. BiotechnologyHealth Technology SOMAí Pharmaceuticals Ltd. is a European pharmaceutical and Irish biotech company that was founded in 2019 by Michael Sassano and George Bellow. The company is based in Dublin, Ireland. SOMAí Pharmaceuticals is a large-scale manufacturer of cannabis products that invests in the extraction, research, development, formulation, and distribution of EU GMP-pharmaceutical market-authorized cannabinoid products. The company is committed to revolutionizing healthcare through cannabis-based treatments and emphasizes scientific pharmacology applications with EU-GMP standards to deliver treatments to the endocannabinoid system. SOMAí Pharmaceuticals is the largest and most advanced cannabinoid manufacturing facility in markets, producing medicines products and registered APIs. Michael Sassano has been the CEO since 2019. | Fondateur | 19/02/2019 |
Anciens postes connus de George Bellow
| Sociétés | Poste | Fin |
|---|---|---|
| UVENCO UK PLC | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Uvenco UK Plc
 Uvenco UK Plc Catalog/Specialty DistributionRetail Trade Uvenco UK Plc installed and operated snack vending machines. It offers high street coffee, watercoolers, hot drink, cold drink and snack and food machines. The company was founded by Blair Ashley Bedford Jenkins in 2001 and was headquartered in London, the United Kingdom. | Retail Trade |
Somaí Pharmaceuticals Ltd.
Somaí Pharmaceuticals Ltd. BiotechnologyHealth Technology SOMAí Pharmaceuticals Ltd. is a European pharmaceutical and Irish biotech company that was founded in 2019 by Michael Sassano and George Bellow. The company is based in Dublin, Ireland. SOMAí Pharmaceuticals is a large-scale manufacturer of cannabis products that invests in the extraction, research, development, formulation, and distribution of EU GMP-pharmaceutical market-authorized cannabinoid products. The company is committed to revolutionizing healthcare through cannabis-based treatments and emphasizes scientific pharmacology applications with EU-GMP standards to deliver treatments to the endocannabinoid system. SOMAí Pharmaceuticals is the largest and most advanced cannabinoid manufacturing facility in markets, producing medicines products and registered APIs. Michael Sassano has been the CEO since 2019. | Health Technology |
